Grants and Contributions:

Back to search
Title:
Development of Cannabis and Nutraceutical infused QuickStrip Products
Agreement Number:
935556
Agreement Value:
$400,000.00
Agreement Date:
Jan 1, 2020 - Dec 31, 2021
Description:
Rapid Dose Therapeutics Corp. (RDT) is a publicly traded Canadian life science company (CSE: DOSE) that develops innovative, proprietary drug delivery technologies designed to improve health and wellness outcomes and improve quality of life. Our QuickStrip™ product line is an oral dissolvable film strip infused with a precise dose of active medicinal ingredient that is rapidly transferred through the oral mucosa under the tongue (sublingual delivery) or inside the mouth (buccal delivery), enabling high bioavailability and fast drug onset time. Our plan is to expand and scale up our product innovation program over 2019-2021 to support the commercial development and scaleup manufacturing of new QuickStrip™ oral thin film products.
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Burlington, Ontario, CA L7N 2G4
Reference Number:
172-2019-2020-Q4-935556
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
716696893
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 275 days.

Amendment Date
Dec 3, 2020
Recipient's Operating Name:
RDT
Recipient's Legal Name:
Rapid Dose Therapeutics Corp.
Federal Riding Name:
Burlington
Federal Riding Number:
35015
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments:
See Amendments